Mehra R et al. Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: pooled analyses after long-term follow-up in KEYNOTE-012. Br J Cancer. 2018 Jul, PMID: 29955135 PublicationBy Sensei TeamDecember 12, 2020…
Ulivieri C et al. Antigenic properties of HCMV peptides displayed by filamentous bacteriophages vs. synthetic peptides. Immunol Lett. 2008, PMID: 18538862 PublicationBy Sensei TeamDecember 12, 2020…
Sartorius R et al. Antigen delivery by filamentous bacteriophage fd displaying an anti-DEC-205 single-chain variable fragment confers adjuvanticity by triggering a TLR9-mediated immune response. EMBO Mol Med. 2015, PMID: 25888235 PublicationBy Sensei TeamDecember 12, 2020…
Sartorius R et al. Arming Filamentous Bacteriophage, a Nature-Made Nanoparticle, for New Vaccine and Immunotherapeutic Strategies. Pharmaceutics. 2019, PMID: 31480551 PublicationBy Sensei TeamDecember 12, 2020…
Prisco A, De Berardinis P. Filamentous bacteriophage fd as an antigen delivery system in vaccination. Int J Mol Sci. 2012, PMID: 22606037 PublicationBy Sensei TeamDecember 12, 2020…
Gaubin M et al. Processing of filamentous bacteriophage virions in antigen-presenting cells targets both HLA class I and class II peptide loading compartments. DNA Cell Biol. 2003, PMID: 12590733 PublicationBy Sensei TeamDecember 12, 2020…
Fausch SC et al. Differential uptake and cross-presentation of human papillomavirus virus-like particles by dendritic cells and Langerhans cells. Cancer Res. 2003, PMID: 12839929 PublicationBy Sensei TeamDecember 12, 2020…
Wan Y, et al. Cross-presentation of phage particle antigen in MHC class II and endoplasmic reticulum marker-positive compartments. Eur J Immunol. 2005, PMID: 15940671 PublicationBy Sensei TeamDecember 12, 2020…
